vs
Alkermes plc.(ALKS)与ROYAL GOLD INC(RGLD)财务数据对比。点击上方公司名可切换其他公司
Alkermes plc.的季度营收约是ROYAL GOLD INC的1.0倍($384.5M vs $375.3M),ROYAL GOLD INC净利率更高(24.9% vs 12.8%,领先12.1%),ROYAL GOLD INC同比增速更快(85.3% vs -10.6%),过去两年ROYAL GOLD INC的营收复合增速更高(58.8% vs 4.8%)
Alkermes plc是一家全产业链布局的生物制药企业,专注于精神障碍与神经系统疾病相关药物的研发。公司1987年由迈克尔·沃尔创立,2011年9月与原Élan集团旗下的药物制剂及生产部门Elan Drug Technologies合并,总部位于都柏林,在马萨诸塞州沃尔瑟姆设有研发中心,俄亥俄州威尔明顿建有生产基地。
Royal Gold Inc.是全球领先的贵金属流权与特许权经营企业,收购并管理多元化的矿业项目流权、净熔炼收益特许权及相关权益,资产覆盖黄金、白银、铜等品类,业务遍及多地区,无需直接承担采矿运营风险。
ALKS vs RGLD — 直观对比
营收规模更大
ALKS
是对方的1.0倍
$375.3M
营收增速更快
RGLD
高出95.9%
-10.6%
净利率更高
RGLD
高出12.1%
12.8%
两年增速更快
RGLD
近两年复合增速
4.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $384.5M | $375.3M |
| 净利润 | $49.3M | $93.6M |
| 毛利率 | 88.0% | 64.6% |
| 营业利润率 | 15.1% | 56.2% |
| 净利率 | 12.8% | 24.9% |
| 营收同比 | -10.6% | 85.3% |
| 净利润同比 | -66.3% | -12.8% |
| 每股收益(稀释后) | $0.29 | $1.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ALKS
RGLD
| Q4 25 | $384.5M | $375.3M | ||
| Q3 25 | $394.2M | $252.1M | ||
| Q2 25 | $390.7M | $209.6M | ||
| Q1 25 | $306.5M | $193.4M | ||
| Q4 24 | $430.0M | $202.6M | ||
| Q3 24 | $378.1M | $193.8M | ||
| Q2 24 | $399.1M | $174.1M | ||
| Q1 24 | $350.4M | $148.9M |
净利润
ALKS
RGLD
| Q4 25 | $49.3M | $93.6M | ||
| Q3 25 | $82.8M | $126.8M | ||
| Q2 25 | $87.1M | $132.3M | ||
| Q1 25 | $22.5M | $113.5M | ||
| Q4 24 | $146.5M | $107.4M | ||
| Q3 24 | $92.4M | $96.2M | ||
| Q2 24 | $91.4M | $81.2M | ||
| Q1 24 | $36.8M | $47.2M |
毛利率
ALKS
RGLD
| Q4 25 | 88.0% | 64.6% | ||
| Q3 25 | 86.9% | 73.6% | ||
| Q2 25 | 87.3% | 72.6% | ||
| Q1 25 | 83.9% | 69.4% | ||
| Q4 24 | 85.6% | 70.3% | ||
| Q3 24 | 83.3% | 66.6% | ||
| Q2 24 | 84.6% | 64.7% | ||
| Q1 24 | 83.3% | 58.4% |
营业利润率
ALKS
RGLD
| Q4 25 | 15.1% | 56.2% | ||
| Q3 25 | 22.6% | 64.4% | ||
| Q2 25 | 23.8% | 67.7% | ||
| Q1 25 | 4.5% | 63.6% | ||
| Q4 24 | 37.8% | 65.9% | ||
| Q3 24 | 27.7% | 61.3% | ||
| Q2 24 | 27.5% | 58.6% | ||
| Q1 24 | 12.4% | 50.7% |
净利率
ALKS
RGLD
| Q4 25 | 12.8% | 24.9% | ||
| Q3 25 | 21.0% | 50.3% | ||
| Q2 25 | 22.3% | 63.1% | ||
| Q1 25 | 7.3% | 58.7% | ||
| Q4 24 | 34.1% | 53.0% | ||
| Q3 24 | 24.4% | 49.7% | ||
| Q2 24 | 22.9% | 46.6% | ||
| Q1 24 | 10.5% | 31.7% |
每股收益(稀释后)
ALKS
RGLD
| Q4 25 | $0.29 | $1.04 | ||
| Q3 25 | $0.49 | $1.92 | ||
| Q2 25 | $0.52 | $2.01 | ||
| Q1 25 | $0.13 | $1.72 | ||
| Q4 24 | $0.88 | $1.63 | ||
| Q3 24 | $0.55 | $1.46 | ||
| Q2 24 | $0.53 | $1.23 | ||
| Q1 24 | $0.21 | $0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $388.6M | $233.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.8B | $7.2B |
| 总资产 | $2.5B | $9.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ALKS
RGLD
| Q4 25 | $388.6M | $233.7M | ||
| Q3 25 | $616.4M | $172.8M | ||
| Q2 25 | $521.2M | $248.2M | ||
| Q1 25 | $399.8M | $240.8M | ||
| Q4 24 | $291.1M | $195.5M | ||
| Q3 24 | $396.3M | $127.9M | ||
| Q2 24 | $535.1M | $74.2M | ||
| Q1 24 | $420.8M | $137.9M |
总债务
ALKS
RGLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $50.0M | ||
| Q1 24 | — | — |
股东权益
ALKS
RGLD
| Q4 25 | $1.8B | $7.2B | ||
| Q3 25 | $1.7B | $3.4B | ||
| Q2 25 | $1.6B | $3.3B | ||
| Q1 25 | $1.5B | $3.2B | ||
| Q4 24 | $1.5B | $3.1B | ||
| Q3 24 | $1.3B | $3.0B | ||
| Q2 24 | $1.3B | $3.0B | ||
| Q1 24 | $1.3B | $2.9B |
总资产
ALKS
RGLD
| Q4 25 | $2.5B | $9.5B | ||
| Q3 25 | $2.3B | $4.5B | ||
| Q2 25 | $2.3B | $3.6B | ||
| Q1 25 | $2.1B | $3.5B | ||
| Q4 24 | $2.1B | $3.4B | ||
| Q3 24 | $2.2B | $3.3B | ||
| Q2 24 | $2.2B | $3.3B | ||
| Q1 24 | $2.1B | $3.3B |
负债/权益比
ALKS
RGLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $170.1M | $241.7M |
| 自由现金流经营现金流 - 资本支出 | $170.0M | — |
| 自由现金流率自由现金流/营收 | 44.2% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 3.45× | 2.58× |
| 过去12个月自由现金流最近4个季度 | $480.3M | — |
8季度趋势,按日历期对齐
经营现金流
ALKS
RGLD
| Q4 25 | $170.1M | $241.7M | ||
| Q3 25 | $101.7M | $174.0M | ||
| Q2 25 | $150.2M | $152.8M | ||
| Q1 25 | $98.8M | $136.4M | ||
| Q4 24 | $190.4M | $141.1M | ||
| Q3 24 | $81.6M | $136.7M | ||
| Q2 24 | $146.0M | $113.5M | ||
| Q1 24 | $21.1M | $138.3M |
自由现金流
ALKS
RGLD
| Q4 25 | $170.0M | — | ||
| Q3 25 | $84.4M | — | ||
| Q2 25 | $137.2M | — | ||
| Q1 25 | $88.7M | — | ||
| Q4 24 | $180.6M | — | ||
| Q3 24 | $73.3M | — | ||
| Q2 24 | $138.9M | — | ||
| Q1 24 | $12.8M | — |
自由现金流率
ALKS
RGLD
| Q4 25 | 44.2% | — | ||
| Q3 25 | 21.4% | — | ||
| Q2 25 | 35.1% | — | ||
| Q1 25 | 28.9% | — | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | 34.8% | — | ||
| Q1 24 | 3.6% | — |
资本支出强度
ALKS
RGLD
| Q4 25 | 0.0% | — | ||
| Q3 25 | 4.4% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 2.4% | — |
现金转化率
ALKS
RGLD
| Q4 25 | 3.45× | 2.58× | ||
| Q3 25 | 1.23× | 1.37× | ||
| Q2 25 | 1.72× | 1.15× | ||
| Q1 25 | 4.40× | 1.20× | ||
| Q4 24 | 1.30× | 1.31× | ||
| Q3 24 | 0.88× | 1.42× | ||
| Q2 24 | 1.60× | 1.40× | ||
| Q1 24 | 0.57× | 2.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALKS
| Vivitrol | $124.1M | 32% |
| Aristada And Aristada Initio | $97.2M | 25% |
| LYBALVI | $94.1M | 24% |
| Royalty | $65.7M | 17% |
| Manufacturing Revenue | $3.3M | 1% |
RGLD
| Gold | $216.9M | 58% |
| Pueblo Viejo | $47.3M | 13% |
| Andacollo | $32.6M | 9% |
| Silver | $32.1M | 9% |
| Other | $27.2M | 7% |
| Copper | $13.7M | 4% |
| Cortez Legacy Zone | $5.4M | 1% |